Literature DB >> 20889146

Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation.

Simona Bancos1, Richard P Phipps.   

Abstract

Worldwide the elderly population is increasing. The elderly show deficiencies in immune function. B lymphocytes are essential elements of the immune system responsible for antibody production. This laboratory previously showed that activated human B cells isolated from young adults express cyclooxygenase-2 (Cox-2) and that Cox-2 is essential for optimal antibody responses. Recent data suggests that Cox-2 expression decreases with age in mouse bone tissue. There is no information regarding Cox-2 expression in B cells from older human subjects. We investigated the expression and activity of Cox-2 in naïve and memory B cells from older people. We show that B cells from older subjects show similar Cox-2 protein expression and activity, antibody production and proliferation compared to younger people. However, we found that activated memory B cells from older people produce higher levels of IL-6 and IL-10 compared to young adults. Therefore, the dysregulated cytokine production could contribute to immune senescence in the elderly.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889146      PMCID: PMC2966539          DOI: 10.1016/j.cellimm.2010.09.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  40 in total

1.  Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population.

Authors:  R Paganelli; I Quinti; U Fagiolo; A Cossarizza; C Ortolani; E Guerra; P Sansoni; L P Pucillo; E Scala; E Cozzi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Ulcer complications and nonsteroidal anti-inflammatory drugs.

Authors:  M J Langman
Journal:  Am J Med       Date:  1988-02-22       Impact factor: 4.965

Review 3.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

Review 4.  Human IgM+CD27+ B cells: memory B cells or "memory" B cells?

Authors:  Stuart G Tangye; Kim L Good
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 5.  Effects of aging on B cell function.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

Review 6.  Biology of immune responses to vaccines in elderly persons.

Authors:  Birgit Weinberger; Dietmar Herndler-Brandstetter; Angelika Schwanninger; Daniela Weiskopf; Beatrix Grubeck-Loebenstein
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

7.  Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells.

Authors:  Simona Bancos; Matthew P Bernard; David J Topham; Richard P Phipps
Journal:  Cell Immunol       Date:  2009-04-05       Impact factor: 4.868

8.  Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM.

Authors:  Yuhui Shi; Kazunaga Agematsu; Hans D Ochs; Kazuo Sugane
Journal:  Clin Immunol       Date:  2003-08       Impact factor: 3.969

9.  Aged B lymphocytes retain their ability to express surface markers but are dysfunctional in their proliferative capability during early activation events.

Authors:  Anthony Blaeser; Kiley McGlauchlen; Laura A Vogel
Journal:  Immun Ageing       Date:  2008-11-17       Impact factor: 6.400

10.  Prevention of arthritis by interleukin 10-producing B cells.

Authors:  Claudia Mauri; David Gray; Naseem Mushtaq; Marco Londei
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

View more
  5 in total

1.  Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.

Authors:  Sanae Sasaki; Meghan Sullivan; Carlos F Narvaez; Tyson H Holmes; David Furman; Nai-Ying Zheng; Madhuri Nishtala; Jens Wrammert; Kenneth Smith; Judith A James; Cornelia L Dekker; Mark M Davis; Patrick C Wilson; Harry B Greenberg; Xiao-Song He
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

2.  Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression.

Authors:  Nina Kim; Katie L Lannan; Thomas H Thatcher; Stephen J Pollock; Collynn F Woeller; Richard P Phipps
Journal:  J Immunol       Date:  2018-10-22       Impact factor: 5.422

3.  Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism.

Authors:  Sesquile Ramon; Simona Bancos; Charles N Serhan; Richard P Phipps
Journal:  Eur J Immunol       Date:  2014-02       Impact factor: 5.532

4.  Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment.

Authors:  Ann M Stowe; Sara J Ireland; Sterling B Ortega; Ding Chen; Ryan M Huebinger; Takashi Tarumi; Thomas S Harris; C Munro Cullum; Roger Rosenberg; Nancy L Monson; Rong Zhang
Journal:  J Neuroinflammation       Date:  2017-07-27       Impact factor: 8.322

5.  Activation of IL-10+ B cells: A novel immunomodulatory mechanism for therapeutic bacterial suspensions.

Authors:  Alberto Salazar; Jane E Nieto; Henry Velazquez-Soto; Maria C Jiménez-Martínez
Journal:  SAGE Open Med       Date:  2020-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.